222 related articles for article (PubMed ID: 31566122)
1. Nanoparticles: Properties and Applications in Cancer Immunotherapy.
Iscaro A; Howard NF; Muthana M
Curr Pharm Des; 2019; 25(17):1962-1979. PubMed ID: 31566122
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
Liu J; Zhang R; Xu ZP
Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
[TBL] [Abstract][Full Text] [Related]
3. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
4. Thermal immuno-nanomedicine in cancer.
Yang Z; Gao D; Zhao J; Yang G; Guo M; Wang Y; Ren X; Kim JS; Jin L; Tian Z; Zhang X
Nat Rev Clin Oncol; 2023 Feb; 20(2):116-134. PubMed ID: 36604531
[TBL] [Abstract][Full Text] [Related]
5. Molecular and nanoengineering approaches towards activatable cancer immunotherapy.
Zhang C; Pu K
Chem Soc Rev; 2020 Jul; 49(13):4234-4253. PubMed ID: 32452475
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology platforms for cancer immunotherapy.
Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.
Torres Andón F; Alonso MJ
J Drug Target; 2015; 23(7-8):656-71. PubMed ID: 26453162
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
[TBL] [Abstract][Full Text] [Related]
9. Advancement of cancer immunotherapy using nanoparticles-based nanomedicine.
Gowd V; Ahmad A; Tarique M; Suhail M; Zughaibi TA; Tabrez S; Khan R
Semin Cancer Biol; 2022 Nov; 86(Pt 2):624-644. PubMed ID: 35378274
[TBL] [Abstract][Full Text] [Related]
10. Nano-immunotherapy: Overcoming tumour immune evasion.
Guevara ML; Persano F; Persano S
Semin Cancer Biol; 2021 Feb; 69():238-248. PubMed ID: 31883449
[TBL] [Abstract][Full Text] [Related]
11. Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy.
Li W; Peng A; Wu H; Quan Y; Li Y; Lu L; Cui M
Front Immunol; 2020; 11():601497. PubMed ID: 33408716
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine for improvement of dendritic cell-based cancer immunotherapy.
Hashemi V; Farhadi S; Ghasemi Chaleshtari M; Seashore-Ludlow B; Masjedi A; Hojjat-Farsangi M; Namdar A; Ajjoolabady A; Mohammadi H; Ghalamfarsa G; Jadidi-Niaragh F
Int Immunopharmacol; 2020 Jun; 83():106446. PubMed ID: 32244048
[TBL] [Abstract][Full Text] [Related]
14. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
[TBL] [Abstract][Full Text] [Related]
16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
17. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
Finn OJ
Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
[TBL] [Abstract][Full Text] [Related]
18. Advancement and Applications of Nanotherapy for Cancer Immune Microenvironment.
He JJ; Li QQ; Zhao C; Zhou J; Wu J; Zhang HB; Zhao YQ; Zhang HH; Lei TY; Zhao XY; You Z; Song QB; Xu B
Curr Med Sci; 2023 Aug; 43(4):631-646. PubMed ID: 37558863
[TBL] [Abstract][Full Text] [Related]
19. Recent advancements in nanomedicine based lipid metabolism for tumour immunotherapy.
Zhao Y; Zhang X; An M; Zhang J; Liu Y
J Drug Target; 2023 Dec; 31(10):1050-1064. PubMed ID: 37962291
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy and nanomedicine.
Sheng WY; Huang L
Pharm Res; 2011 Feb; 28(2):200-14. PubMed ID: 20821040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
